Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, … Tylenol made $48.7 billion consumer brands dealRead more
Tylenol
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, … Tylenol made $48.7 billion consumer brands dealRead more